Join CBSET at TCT 2017, October 29 – November 2, at the Colorado Convention Center, Denver, CO.
CBSET Chairman, Elazer Edelman, MD, PhD, will be receiving the prestigious TCT 2017 Career Achievement Award on Monday, October 30 during the 8:00 AM – 1:00 PM session in the Main Arena I, Bellco Theater, Meeting Room Level.
Dr. Edelman will also be presenting several sessions, including:
- Metallic DES: What can we expect from new drugs, polymers, and metals? Have we reached the Limit of Iterative Development? on Monday, October 30, at 2:24 PM, as part of Didactic Session: Metallic Drug – Eluting Stents and Coronary Drug – Coated Balloons – New Directions.
- Refining the classic definition of aortic stenosis: Interpretation including the role of ventricular stroke work and vascular impedance, on Monday, October 30 at 2:00 PM, as part of Didactic Session: Transcatheter Aortic Valve Therapies, Part 1 – Novel, Provocative, and Controversial Topics in Aortic Valve Disease and Evolving Clinical Indications for TAVR
- Insights into Asymmetric Scaffold Bioreabsorption and Failure Mechanism on Wednesday, November 1, at 1:00 PM, as part of Didactic Session: Bioresorbable Vascular Scaffolds, Part 2 – Case Selection and Technique
On Tuesday, October 31, at 1:00 PM, CBSET’s Director of Research and Innovation, Rami Tzafriri, PhD, will be presenting “Stent-Based Tissue Drug and Binding Target Protein Distributions – Durable vs Deployable Coatings”, as part of Oral Abstract Session 2B: Healing After DES Implantation.
CBSET will be exhibiting in booth # 3061. If you would like to meet up with us at the event, please contact us.